AR016540A1 - Compuestos y sales con propiedades organolepticas beneficiosas, procedimiento para su preparacion, su utilizacion para la preparacion de composicionesfarmaceuticas y composiciones farmaceuticas que los contienen - Google Patents
Compuestos y sales con propiedades organolepticas beneficiosas, procedimiento para su preparacion, su utilizacion para la preparacion de composicionesfarmaceuticas y composiciones farmaceuticas que los contienenInfo
- Publication number
- AR016540A1 AR016540A1 ARP980103653A ARP980103653A AR016540A1 AR 016540 A1 AR016540 A1 AR 016540A1 AR P980103653 A ARP980103653 A AR P980103653A AR P980103653 A ARP980103653 A AR P980103653A AR 016540 A1 AR016540 A1 AR 016540A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- pharmaceutical compositions
- compounds
- salts
- procedure
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 230000009286 beneficial effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract 2
- 150000002500 ions Chemical class 0.000 abstract 2
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 abstract 2
- 229960000620 ranitidine Drugs 0.000 abstract 2
- -1 slegiline Chemical compound 0.000 abstract 2
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 abstract 1
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 229960004099 azithromycin Drugs 0.000 abstract 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 abstract 1
- 235000019658 bitter taste Nutrition 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 229960001380 cimetidine Drugs 0.000 abstract 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 abstract 1
- 229960003405 ciprofloxacin Drugs 0.000 abstract 1
- 229960002626 clarithromycin Drugs 0.000 abstract 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 abstract 1
- 229960003009 clopidogrel Drugs 0.000 abstract 1
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 abstract 1
- 229960003276 erythromycin Drugs 0.000 abstract 1
- 229960002464 fluoxetine Drugs 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- PXZDWASDNFWKSD-UHFFFAOYSA-N prenoxdiazine Chemical compound C1CCCCN1CCC(ON=1)=NC=1CC(C=1C=CC=CC=1)C1=CC=CC=C1 PXZDWASDNFWKSD-UHFFFAOYSA-N 0.000 abstract 1
- 229960004202 prenoxdiazine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 235000019605 sweet taste sensations Nutrition 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Seasonings (AREA)
Abstract
Compuestos y sales con propiedades organolépticas beneficiosas con la formula general:A - X en la que A representa un ion cargado positivamente (cation) dedrotaverina, prenoxdiazina, slegilina, azitromicina, cimetidina, ciprofloxacina, clopidogrel,i rbesartan,eritromicina, fluoxetina, ranitidina,claritromicina,enalaril, X es un ion cargado negativamente(anion)de un edulcorante, y sus solvatos. Procedimiento para su preparacion, su utilizacion para la preparacion dede composicionesfarmacéuticas y composiciones farmacéuticas que los contienen. Estos compuestos exhiben en la aplicacion oral, un agradable gusto dulce inagudo que es preferible al contrastante desagradable gusto amargo de los compuestos conocidos en el estado dela técnica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9701293A HUP9701293A3 (en) | 1997-07-25 | 1997-07-25 | New salts without unsavoury taste and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR016540A1 true AR016540A1 (es) | 2001-07-25 |
Family
ID=89995415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103653A AR016540A1 (es) | 1997-07-25 | 1998-07-24 | Compuestos y sales con propiedades organolepticas beneficiosas, procedimiento para su preparacion, su utilizacion para la preparacion de composicionesfarmaceuticas y composiciones farmaceuticas que los contienen |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1003557B1 (es) |
| AR (1) | AR016540A1 (es) |
| AU (1) | AU8553598A (es) |
| EA (1) | EA002719B1 (es) |
| EE (1) | EE04098B1 (es) |
| GE (1) | GEP20022613B (es) |
| HR (1) | HRP20000037A2 (es) |
| HU (1) | HUP9701293A3 (es) |
| PL (1) | PL344038A1 (es) |
| SK (1) | SK284641B6 (es) |
| TW (1) | TW509569B (es) |
| UA (1) | UA69390C2 (es) |
| WO (1) | WO1999004822A2 (es) |
| YU (1) | YU3400A (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10013712A1 (de) * | 2000-03-20 | 2001-09-27 | Nutrinova Gmbh | Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US20020081360A1 (en) * | 2000-12-27 | 2002-06-27 | Andreas Burgard | Salts of L-amino acid having improved taste and their preparation |
| DE10130504B4 (de) | 2001-06-25 | 2005-02-03 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Xanthin- und Phenazon-Acesulfam-H-Komplexe mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung |
| WO2009074351A2 (en) * | 2007-12-12 | 2009-06-18 | Ultimorphix Technologies B.V. | Solid forms of tenofovir disoproxil |
| US7935817B2 (en) * | 2008-03-31 | 2011-05-03 | Apotex Pharmachem Inc. | Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof |
| CN103664781B (zh) * | 2013-12-13 | 2015-12-09 | 浙江普洛康裕制药有限公司 | 盐酸屈他维林晶型i和晶型ii及制备方法 |
| CN103694171B (zh) * | 2013-12-13 | 2016-06-29 | 浙江普洛康裕制药有限公司 | 盐酸屈他维林晶型iii和晶型iv及其制备方法 |
| WO2024023785A1 (en) * | 2022-07-29 | 2024-02-01 | Berlia Sushma Paul | A stable pharmaceutical oral liquid formulation of an antispasmodic agent |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE621917A (es) * | ||||
| GB1577196A (en) * | 1977-06-03 | 1980-10-22 | Ile De France | Compositions containing erythromycin and metoclopramide |
| FR2633181B1 (fr) * | 1988-06-24 | 1992-01-10 | Glaxo Lab Sa | Composition pharmaceutique a base de ranitidine et son procede de preparation |
| AU627775B2 (en) * | 1988-09-20 | 1992-09-03 | Glaxo Group Limited | Pharmaceutical compositions |
-
1997
- 1997-07-25 HU HU9701293A patent/HUP9701293A3/hu unknown
-
1998
- 1998-07-14 TW TW087111464A patent/TW509569B/zh active
- 1998-07-22 EP EP98936573A patent/EP1003557B1/en not_active Expired - Lifetime
- 1998-07-22 SK SK107-2000A patent/SK284641B6/sk unknown
- 1998-07-22 EA EA200000160A patent/EA002719B1/ru not_active IP Right Cessation
- 1998-07-22 UA UA2000021067A patent/UA69390C2/uk unknown
- 1998-07-22 EE EEP200000049A patent/EE04098B1/xx not_active IP Right Cessation
- 1998-07-22 GE GEAP19985234A patent/GEP20022613B/en unknown
- 1998-07-22 AU AU85535/98A patent/AU8553598A/en not_active Abandoned
- 1998-07-22 WO PCT/HU1998/000066 patent/WO1999004822A2/en not_active Application Discontinuation
- 1998-07-22 PL PL98344038A patent/PL344038A1/xx not_active IP Right Cessation
- 1998-07-22 YU YU3400A patent/YU3400A/sh unknown
- 1998-07-24 AR ARP980103653A patent/AR016540A1/es unknown
-
2000
- 2000-01-25 HR HR20000037A patent/HRP20000037A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1003557B1 (en) | 2003-05-02 |
| WO1999004822A3 (en) | 1999-08-12 |
| UA69390C2 (uk) | 2004-09-15 |
| EE04098B1 (et) | 2003-08-15 |
| PL344038A1 (en) | 2001-09-24 |
| WO1999004822A2 (en) | 1999-02-04 |
| YU3400A (sh) | 2002-03-18 |
| SK1072000A3 (en) | 2000-11-07 |
| EP1003557A2 (en) | 2000-05-31 |
| HRP20000037A2 (en) | 2000-10-31 |
| GEP20022613B (en) | 2002-01-25 |
| TW509569B (en) | 2002-11-11 |
| EA200000160A1 (ru) | 2000-10-30 |
| HU9701293D0 (en) | 1997-09-29 |
| HUP9701293A2 (hu) | 1999-02-01 |
| EA002719B1 (ru) | 2002-08-29 |
| SK284641B6 (sk) | 2005-08-04 |
| AU8553598A (en) | 1999-02-16 |
| EE200000049A (et) | 2000-10-16 |
| HUP9701293A3 (en) | 1999-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA875179B (en) | Taxol derivatives,their preparation and pharmaceutical compositions containing them | |
| ES2162614T1 (es) | Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas. | |
| BR0214757A (pt) | Formulações farmacêuticas de derivados de platina | |
| MX9203114A (es) | Nuevos derivados morfolino de daunorubicina y doxorubicina y composiciones farmaceuticas que los contienen. | |
| DE60123277D1 (de) | Makrolidantibiotika | |
| AR016540A1 (es) | Compuestos y sales con propiedades organolepticas beneficiosas, procedimiento para su preparacion, su utilizacion para la preparacion de composicionesfarmaceuticas y composiciones farmaceuticas que los contienen | |
| IT8420940A0 (it) | Sali stabili della solfo-adenosil-l-metionina (same)particolarmente idonei per uso farmaceutico orale. | |
| ES2009723A4 (es) | Derivados de acidos biliares, procedimientos para la preparacion de los mismos y composiciones farmaceuticas conteniendolos. | |
| DK228385D0 (da) | 1-heteroaryl-4-aryl-pyrazolin-5-oner, deres fremstilling og anvendelse som mikrobiocider | |
| ES509961A0 (es) | Procedimiento para la obtencion de una sal comun dietetica especialmente destinada al consumo humano. | |
| ID27281A (id) | Sediaan bahan farmasi yang mengandung levotiroksin natrium | |
| BRPI9910024B8 (pt) | uso de uma mistura de alcoóis de açúcar contendo 6-o-alfa-d-glicopiranosil-d-sorbitol (1,6-gps) e 1-o-alfa-d-glicopiranosil-d-manitol (1,1-gpm) in vitro, e composição farmacêutica para consumo humano ou animal | |
| IT8322621A0 (it) | Composizioni terapeutiche per uso orale contenenti sali stabili della s-adenosil-l-metionina. | |
| CA2012046A1 (en) | Use of 5'-deoxy-5'-methylthioadenosine, s-adenosylmethionine and their salts for reducing seborrhea | |
| BR9915729A (pt) | Amidas Èmega de n-arilsulfonil-aminoácido | |
| NO970178L (no) | Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler | |
| ECSP034530A (es) | Derivados de 6-metil-tramadol sustituido en o | |
| IT8548977A0 (it) | Composizioni effervescenti clorate per pastiglie per uso di disinfezione | |
| ES2037682T3 (es) | Procedimiento para la preparacion de composiciones farmaceuticas empleando quitosanos metilados. | |
| ES2243558T3 (es) | Empleo de ectoina o de derivados de ectoina para el cuidado de la boca. | |
| NO821841L (no) | Mettede aminocyklitderivater, deres fremstilling og legemiddel inneholdende dem | |
| ES547855A0 (es) | Procedimiento para la preparacion de nuevas sales fisiologi-camente activas o aceptables de sabor dulce | |
| IT8522327A0 (it) | Derivati macromolecolarizzati di cdp-colina, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono. | |
| PT1202956E (pt) | Derivados terapeuticos e/ou nuricionalmente melhorados de ingredientes activos e composicoes de administracao oral contendo o mesmo | |
| OA08130A (fr) | Compositions pharmaceutiques ou vétérinaires contenant des dérivés thiosulfonates. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |